Injecting Safety into Supplements — Modernizing the Dietary Supplement Law | NEJM
Perspective from The New England Journal of Medicine — Injecting Safety into Supplements — Modernizing the Dietary Supplement Law
Perspective from The New England Journal of Medicine — Injecting Safety into Supplements — Modernizing the Dietary Supplement Law
HLH, a cytokine-mediated hyperinflammation syndrome, causes fever, pancytopenia, and hemophagocytosis and is often fatal. Antiinflammatory agents, etoposide, and interferon-γ antibody are the main …
Original Article from The New England Journal of Medicine — Pelvic Inclination: A Factor in Slipped Epiphysis and Nonunion of Fracture of the Hip
A 35-year-old man presented with a 2-year history of proximal muscle weakness with intermittent muscle cramping. Physical examination showed macroglossia and enlargement of the muscles…
State Medicaid agencies can now apply to participate in a new model that supports voluntary, outcomes-based agreements between Medicaid programs and manufacturers of gene therapies…
Quick Take Video Summary from The New England Journal of Medicine — Atrasentan for IgA Nephropathy
Image Challenge from the New England Journal of Medicine — February 6, 2025
No medications are currently approved for the treatment of nonmonogenic, nonsyndromic obesity in children younger than 12 years of age. Although the use of liraglutide…
No medications are currently approved for the treatment of nonmonogenic, nonsyndromic obesity in children younger than 12 years of age. Although the use of liraglutide…
Xenotransplantation offers a potential solution to the organ shortage crisis. A 62-year-old hemodialysis-dependent man with long-standing diabetes, advanced vasculopathy, and marked dialysis-access…
Quick Take Video Summary from The New England Journal of Medicine — Iptacopan in IgA Nephropathy